173 related articles for article (PubMed ID: 19903243)
21. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
[TBL] [Abstract][Full Text] [Related]
22. Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death.
Lison H; Happel MF; Schneider F; Baldauf K; Kerbstat S; Seelbinder B; Schneeberg J; Zappe M; Goldschmidt J; Budinger E; Schröder UH; Ohl FW; Schilling S; Demuth HU; Scheich H; Reymann KG; Rönicke R
Neurobiol Dis; 2014 Mar; 63():62-73. PubMed ID: 24291517
[TBL] [Abstract][Full Text] [Related]
23. Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticus.
Mori F; Okada M; Tomiyama M; Kaneko S; Wakabayashi K
Epilepsy Res; 2005 Jun; 65(1-2):59-70. PubMed ID: 15979854
[TBL] [Abstract][Full Text] [Related]
24. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.
Peng S; Garzon DJ; Marchese M; Klein W; Ginsberg SD; Francis BM; Mount HT; Mufson EJ; Salehi A; Fahnestock M
J Neurosci; 2009 Jul; 29(29):9321-9. PubMed ID: 19625522
[TBL] [Abstract][Full Text] [Related]
25. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
[TBL] [Abstract][Full Text] [Related]
27. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
[TBL] [Abstract][Full Text] [Related]
28. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h.
Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC
Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247
[TBL] [Abstract][Full Text] [Related]
29. Ca2+ dysregulation in neurons from transgenic mice expressing mutant presenilin 2.
Kipanyula MJ; Contreras L; Zampese E; Lazzari C; Wong AK; Pizzo P; Fasolato C; Pozzan T
Aging Cell; 2012 Oct; 11(5):885-93. PubMed ID: 22805202
[TBL] [Abstract][Full Text] [Related]
30. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models.
Stutzmann GE; Smith I; Caccamo A; Oddo S; Parker I; Laferla F
Ann N Y Acad Sci; 2007 Feb; 1097():265-77. PubMed ID: 17413028
[TBL] [Abstract][Full Text] [Related]
31. Differential alterations in expressions of ryanodine receptor subtypes in cerebellar cortical neurons of an ataxic mutant, rolling mouse Nagoya.
Sawada K; Hosoi E; Bando M; Sakata-Haga H; Lee NS; Jeong YG; Fukui Y
Neuroscience; 2008 Mar; 152(3):609-17. PubMed ID: 18313230
[TBL] [Abstract][Full Text] [Related]
32. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
33. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
[TBL] [Abstract][Full Text] [Related]
34. A Gating Mutation in Ryanodine Receptor Type 2 Rescues Phenotypes of Alzheimer's Disease Mouse Models by Upregulating Neuronal Autophagy.
Zhang H; Knight C; Chen SRW; Bezprozvanny I
J Neurosci; 2023 Feb; 43(8):1441-1454. PubMed ID: 36627208
[TBL] [Abstract][Full Text] [Related]
35. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
36. CREB-regulated transcription coactivator 1-dependent transcription in Alzheimer's disease mice.
Saura CA
Neurodegener Dis; 2012; 10(1-4):250-2. PubMed ID: 22236576
[TBL] [Abstract][Full Text] [Related]
37. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
38. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
39. Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology.
Schrank S; McDaid J; Briggs CA; Mustaly-Kalimi S; Brinks D; Houcek A; Singer O; Bottero V; Marr RA; Stutzmann GE
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033164
[TBL] [Abstract][Full Text] [Related]
40. Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.
Yao J; Sun B; Institoris A; Zhan X; Guo W; Song Z; Liu Y; Hiess F; Boyce AKJ; Ni M; Wang R; Ter Keurs H; Back TG; Fill M; Thompson RJ; Turner RW; Gordon GR; Chen SRW
Cell Rep; 2020 Sep; 32(12):108169. PubMed ID: 32966798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
